Coexistence hepatitis viral sharp type to and typhoid fever in patient pediatric
DOI:
https://doi.org/10.56294/saludcyt20251618Keywords:
typhoid fever, hepatitis, icterus, hepatomegalyAbstract
Introduction: The typhoid fever is a sharp, systemic, serious feverish illness, caused by bacteria negative Gram; of the gender Salmonella enteric serotype tophi and paratyphoid, oral fecal transmission. The hepatitis TO (there is) it is an illness of world distribution whose incidence is bigger in geographical areas with sanitary hygienic faulty conditions. The transmission is person to person for via fecal oral. Objective: To describe case of patient with coexistence of typhoid fever and hepatitis viral sharp type A. Description of the case: Patient feminine of 10 years, origin rural, faulty habits of hygiene, enters in Pediatric Hospital José Luis Miranda for taking of the general state, more intense diffuse abdominal pain in right hypochondriac, fever of 5 days of evolution, diarrheas liquidate voluminous and frequent, to the physical exam: pale, with slight icterus and hepatomegaly. Result of the coprocultivo is received where you aisle Salmonella Tippy and abdominal ultrasound with hepatomegaly, light hepatic esteatosis, diffuse engrosamin of the vesicular wall, compatible with an inflammatory process of the hepatic parequim. Markers positive hepatitis serológicos, IgM for Hepatitis A. Discussion: The typhoid fever and the hepatitis viral sharp type TO they are illnesses related with the poverty, the lack of personal hygiene and the consumption of water and foods contaminated In the presented case the confirmation diagnostic of the coexistence of both illnesses he/she is carried out for the epidemic clinical investigation and laboratory studies. Conclusions: The coexistence typhoid fever and hepatitis viral type TO it is not a frequent fact in the medical practice that you confirms for laboratory exams.
References
1. Sanhueza Palma NC, Farías Molina S, Calzadilla Riveras J, Hermoso A. Fiebre tifoidea: reporte de caso y revisión de la literatura. [Internet]. 2021 [citado 9/8/2022]; 5(1): [aprox. 15 pant.]. Disponible en: doi: 10.5867/medwave.2016.05.6474.
2. Jurado Jimènez CR, Arenas Muñoz C, Doblas A, Delgado A, Rivero J, Torre-Cisneros. Fiebre tifoidea y otras infecciones causadas por salomnellas Medicine. [Internet]. 2021 [citado 9/8/2022]; 15(2): [aprox. 1 pant.]. Disponible en: https://www.google.com/url?sa=t&source=web&rct=j&url=http://repositorio.ual.es/handle/10835/9862&ved=2ahUKEwjzqbb_wsLxAhUNlmoFHaYhCzIQFjAAegQIBBAC&usg=AOvVaw2-CoGKUXXovJCoxDevRDOQ
3. Valenzuela Flores AA, Hernández Cid de León S, Rábago Rodríguez MR, Sánchez Huerta G. Guía de práctica clínica. Diagnóstico y Tratamiento para la Fiebre Tifoidea. . [Internet]. 2018 [citado 9/8/2022]. Disponible en http://imss.gob.mx/profesionales-salud/gpc.http://www.cenetec.salud.gob.mx/contenidos/gpc/catalogoMaestroGPC.htm
4. Chand H, Raj Rijal K, Neupane B, Kumar V, Jha B. Reemergence of susceptibility to conventional first line drugs in Salmonella isolates from enteric fever patients in Nepal. J Infect Dev Ctries. 2018; 8(11):1483-1487.
5. Buckle G, Fischer C, Black R, Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2018. [Internet]. 2018 [citado 9/8/2022]. Disponible en: http://doi: 10.7189/jogh.02.010401.
6. Carrada Bravo. Fiebre tifoidea: caso clínico, estudio epidemiológico, patogenia, diagnóstico y tratamiento. Med Int Mex .2018; 23(5):447-57.
7. Storey HL, Huang Y, Crudder C, Golden A, de los Santos T, Hawkins K. A Meta-Analysis of Typhoid Diagnostic Accuracy Studies: A Recommendation to Adopt a Standardized Composite Reference. [Internet]. 2019 [citado 9/8/2022]; 10(11): [aprox. 15 pant.]. Disponble en: 10.1371/journal.pone.0142364
8. CDC. Centers for disease control and prevention. Health information for international travel. New York: Oxford university press; 2016. 9.
9. Alonso R, Aguilera A, Córdova J, Fuertes A. Diagnóstico microbiológico de las hepatitis virales. Enfermedades infecciosas y Microbiología Cínica. [Internet]. 2019 [citado 9/8/2022]; 33(9): [aprox. 5 pant.]. Disponble en: 10.1016/j.eimc.2014.08.002
10. Comité Asesor de Vacunas. Hepatitis A. Manual de vacunas en línea de la AEP. [Internet]. 2020 [citado 9/8/2022]; 7(1): [aprox. 15 pant.]. Disponble en: http://vacunasaep.org/documentos/manual/cap-28.2.
11. AAP. Hepatitis A. Red Book Atlas of Pediatric Infectious Diseases. Am Acad Pediat. 2015; p.391- 399.
12. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Red Nacional de Vigilancia Epidemiológica. Protocolos de la Red Nacional de Vigilancia Epidemiológica. Madrid, 2017.
13. Grande Tejada A Mª, Romero García A. Actualización en el diagnóstico, abordaje y prevención de la hepatitis A. Grupo de Patología Infecciosa de la Asociación Española de Pediatría de Atención primaria. Hepatitis A. 2019. Disponible en: http://www.aepap.org/grupos/grupo-de- patología infecciosa/contenido/documentos
14. Chertorivski Woldenberg S, Kuri Morales PA, Fajardo Dolci GE, Valencia IR, González Roldán JF. Manual de Procedimientos Estandarizados para la Vigilancia Epidemiológica de las Hepatitis Virales. Dirección General de Epidemiología. Ministerio de Salud de Mexico.2018.
15. Rodríguez Silva L. Hepatitis virales agudas. En: P. Jara, ed. Enfermedad hepática en el niño. Ed: Tile Von Spain; 2018. p. 205-31.
Published
Issue
Section
License
Copyright (c) 2025 Dionis Ruiz Reyes, Néstor Miguel Carvajal-Otaño , Madyaret Águila Carbelo , Adriel Herrero Díaz, Ileana Beatriz Quiroga López (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
